Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Paysign, Inc. (TPNL) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "Paysign, Inc. Reports Second Quarter 2023 Financial Results · Second quarter total revenues of $11.0 million, an increase of 28% compared to second quarter 2022 · Second quarter net loss of million and diluted loss per share of · Second quarter Adjusted EBITDA of $1.1 million, an increase of 23% compared to second quarter 2022, and diluted Adjusted EBITDA per share of $0.02, unchanged from second quarter 2022 · Added four net new plasma donation centers during the second quarter, exiting the quarter with 443 centers · Launched five new patient affordability programs during the second quarter, exiting the quarter with 31 active programs, leading to a 133% increase in pharma patient affordability revenue · Second quarter gross dollar load volume up 7..."
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "2023 EQUITY INCENTIVE PLAN"
03/28/2023 8-K Quarterly results
03/24/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/24/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/22/2023 10-K Annual Report for the period ended December 31, 2022
03/21/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Forward-Looking Statements"
03/21/2023 8-K Quarterly results
Docs: "Company’ s Board Authorizes $5 Million Share Repurchase Program For the Full Year · Full-year 2022 total revenues of $38.0 million, up 29% from full-year 2021 · Full-year 2022 net income of $1.0 million, or diluted earnings per share of $0.02 · Full-year 2022 Adjusted EBITDA of $5.5 million, up 175% from $2.0 million a year ago, while diluted Adjusted EBITDA per share was $0.10 versus $0.04 for full-year 2021 · Added 78 net plasma donation centers during 2022, exiting the year with 444 centers · Full-year 2022 gross dollar load volume was up 40% over 2021 · Full-year 2022 gross spend volume was up 47% over 2021 For the Fourth Quarter · Fourth quarter total revenues of $10.6 million, up 21% from fourth quarter 2021 · Fourth quarter net..."
02/27/2023 8-K Shareholder Nominations Pursuant to Exchange Act Rule 14a-11  Interactive Data
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/22/2022 8-K Quarterly results
11/09/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/08/2022 8-K Quarterly results
Docs: "Paysign, Inc. Reports Third Quarter 2022 Financial Results · Third quarter total revenues of $10.6 million, an increase of $2.8 million from third quarter 2021 · Third quarter net income of $0.85 million, or diluted earnings per share of $0.02 · Third quarter Adjusted EBITDA of $1.9 million, or diluted Adjusted EBITDA per share of $0.04 · Added 13 plasma donation centers during the third quarter, bringing the year-to-date total additions to 84 · Third quarter gross dollar load volume up 57.6% versus the year-ago period and up 23.1% versus the previous quarter · Third quarter purchase volume was up 58.6% versus the year-ago period and up 22.9% versus the previous quarter HENDERSON, Nev. – November 8, 2022 – – Paysign, Inc. , a leading provider of pr..."
11/01/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
10/18/2022 8-K Quarterly results
09/02/2022 8-K Shareholder Nominations Pursuant to Exchange Act Rule 14a-11  Interactive Data
08/10/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/09/2022 8-K Quarterly results
Docs: "Paysign, Inc. Reports Second Quarter 2022 Financial Results · Second quarter total revenues of $8.6 million, an increase of $1.9 million from second quarter 2021 · Second quarter net loss of $0.2 million, or diluted net loss per share of · Second quarter Adjusted EBITDA of $0.9 million, or diluted Adjusted EBITDA per share of $0.02 · Added 62 plasma donation centers during the second quarter bringing the first half total additions to 71 · Second quarter gross dollar load volume up 40.5% versus the year-ago period and 16.1% versus the previous quarter · Second quarter purchase volume was up 45.7% versus the year-ago period and 26.8% versus the previous quarter · Engaged Moss Adams LLP as the company’ s independent registered public accounting..."
08/09/2022 8-K Resignation/termination of a director, Appointed a new director
Docs: "Resignation Letter from Daniel H. Spence",
"Paysign Announces Changes to the Board of Directors"
08/03/2022 8-K Changes in Registrant's Certifying Accountant  Interactive Data
05/12/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/11/2022 8-K Quarterly results
05/02/2022 10-K/A Annual Report for the period ended December 31, 2021 [amend]
04/08/2022 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
03/23/2022 10-K Annual Report for the period ended December 31, 2021
03/22/2022 8-K Quarterly results
Docs: "Paysign, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results · Fourth quarter total revenues of $8.8 million, an increase of $1.5 million from fourth-quarter 2020 · Fourth quarter net income of $0.1 million, or diluted earnings per share of $0.00 · Fourth quarter adjusted EBITDA of $1.3 million, or diluted adjusted EBITDA per share of $0.02 · Fourth quarter gross dollar load volume up 12.5% versus the year-ago period and 4.6% versus the previous quarter · Fourth quarter purchase volume up 13.2% versus the year-ago period and up 5.4% versus the previous quarter HENDERSON, Nev. – March 22, 2022 – – Paysign, Inc. , a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated ..."
01/20/2022 SC 13G Topline Capital Management, LLC reports a 5.1% stake in Paysign, Inc.
11/10/2021 10-Q Quarterly Report for the period ended September 30, 2021
11/09/2021 8-K Quarterly results
Docs: "Paysign, Inc. Reports Third-Quarter 2021 Financial Results · Third-quarter total revenues of $7.8 million, a year-over-year increase of $7.9 million · Third-quarter plasma revenue of $7.0 million, a year-over-year increase of $1.8 million or 35.6% · Third-quarter net loss of $0.3 million, or diluted earnings per share of · Third-quarter adjusted EBITDA of $1.0 million, or diluted adjusted EBITDA per share of $0.02 · Third-quarter purchase transactions and purchase dollar volume increased 14.6% and 33.9% year-over-year, respectively · Third-quarter total loads and total gross dollar load volume increased 1.9% and 24.7% year-over-year, respectively HENDERSON, Nev. – November 9, 2021- – – Paysign, Inc. , a leading provider of prepaid card programs, co..."
10/06/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/01/2021 144 Form 144 - Report of proposed sale of securities:
08/11/2021 10-Q Quarterly Report for the period ended June 30, 2021
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy